Precision Immunotherapy to Improve Sepsis Outcomes

This randomized trial assesses whether precision immunotherapy tailored to macrophage activation–like syndrome or sepsis-induced immunoparalysis improved organ dysfunction compared with placebo among patients with sepsis.